Ekso Bionics to Report Second Quarter 2021 Financial Results on July 29, 2021
RICHMOND, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2021 after the close of trading on Thursday, July 29, 2021.
- RICHMOND, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2021 after the close of trading on Thursday, July 29, 2021.
- ET to discuss the financial results and recent business developments.
- Founded in 2005, Ekso Bionics continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market.
- Ekso Bionics is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO.